Micron Solutions (OTCMKTS:MICR) and Delcath Systems (NASDAQ:DCTH) Critical Review

Micron Solutions (OTCMKTS:MICR) and Delcath Systems (NASDAQ:DCTH) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, profitability, institutional ownership, valuation, dividends, analyst recommendations and risk.

Valuation and Earnings

This table compares Micron Solutions and Delcath Systems”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Micron Solutions	N/A	N/A	N/A	($0.36)	0.00
Delcath Systems	$37.21 million	9.40	-$26.39 million	$0.01	991.00

Micron Solutions has higher earnings, but lower revenue than Delcath Systems. Micron Solutions is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Micron Solutions has a beta of 0.12, suggesting that its share price is 88% less volatile than the S&P 500. Comparatively, Delcath Systems has a beta of 0.37, suggesting that its share price is 63% less volatile than the S&P 500.

Institutional and Insider Ownership

61.1% of Delcath Systems shares are owned by institutional investors. 26.1% of Micron Solutions shares are owned by insiders. Comparatively, 17.9% of Delcath Systems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares Micron Solutions and Delcath Systems’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Micron Solutions	N/A	N/A	N/A
Delcath Systems	1.50%	7.02%	6.39%

Analyst Recommendations

This is a breakdown of recent ratings for Micron Solutions and Delcath Systems, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Micron Solutions	0	0	0	0	0.00
Delcath Systems	1	0	5	0	2.67

Delcath Systems has a consensus target price of $22.40, indicating a potential upside of 126.03%. Given Delcath Systems’ stronger consensus rating and higher probable upside, analysts plainly believe Delcath Systems is more favorable than Micron Solutions.

Summary

Delcath Systems beats Micron Solutions on 11 of the 12 factors compared between the two stocks.

About Micron Solutions

Micron Solutions, Inc. operates as a contract manufacturer for the medical device, defense, and life sciences markets. It offers precision machining, thermoplastic injection molding, mold making products; sensors; orthopedic implants and devices; and diagnostic test kits. The company provides solutions for medical, orthopedics, consumer, and automotive industries. Micron Solutions, Inc. was founded in 1978 and is based in Fitchburg, Massachusetts.

About Delcath Systems

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company’s lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.